Tsuruo T - Search Results

1

Retroviral expression of a mutant (Gly-533) human DNA topoisomerase I cDNA confers a dominant form of camptothecin resistance.

Yanase K, Sugimoto Y, Andoh T, Tsuruo T. Yanase K, et al. Among authors: tsuruo t. Int J Cancer. 1999 Mar 31;81(1):134-40. doi: 10.1002/(sici)1097-0215(19990331)81:1<134::aid-ijc22>3.0.co;2-y. Int J Cancer. 1999. PMID: 10077164

2

Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization.

Kage K, Tsukahara S, Sugiyama T, Asada S, Ishikawa E, Tsuruo T, Sugimoto Y. Kage K, et al. Among authors: tsuruo t. Int J Cancer. 2002 Feb 10;97(5):626-30. doi: 10.1002/ijc.10100. Int J Cancer. 2002. PMID: 11807788

3

Decreased expression of DNA topoisomerase I in camptothecin-resistant tumor cell lines as determined by a monoclonal antibody.

Sugimoto Y, Tsukahara S, Oh-hara T, Isoe T, Tsuruo T. Sugimoto Y, et al. Among authors: tsuruo t. Cancer Res. 1990 Nov 1;50(21):6925-30. Cancer Res. 1990. PMID: 2170010

4

Elevated expression of DNA topoisomerase II in camptothecin-resistant human tumor cell lines.

Sugimoto Y, Tsukahara S, Oh-hara T, Liu LF, Tsuruo T. Sugimoto Y, et al. Among authors: tsuruo t. Cancer Res. 1990 Dec 15;50(24):7962-5. Cancer Res. 1990. PMID: 2174738

5

Expression of P-glycoprotein mRNA in human gastric tumors.

Sugimoto Y, Asami N, Tsuruo T. Sugimoto Y, et al. Among authors: tsuruo t. Jpn J Cancer Res. 1989 Oct;80(10):993-9. doi: 10.1111/j.1349-7006.1989.tb01639.x. Jpn J Cancer Res. 1989. PMID: 2575610 Free PMC article.

6

Coexpression of a multidrug resistance gene (MDR1) and herpes simplex virus thymidine kinase gene in a bicistronic retroviral vector Ha-MDR-IRES-TK allows selective killing of MDR1-transduced human tumors transplanted in nude mice.

Sugimoto Y, Sato S, Tsukahara S, Suzuki M, Okochi E, Gottesman MM, Pastan I, Tsuruo T. Sugimoto Y, et al. Among authors: tsuruo t. Cancer Gene Ther. 1997 Jan-Feb;4(1):51-8. Cancer Gene Ther. 1997. PMID: 9012451

7

Retroviral coexpression of two different types of drug resistance genes to protect normal cells from combination chemotherapy.

Suzuki M, Sugimoto Y, Tsukahara S, Okochi E, Gottesman MM, Tsuruo T. Suzuki M, et al. Among authors: tsuruo t. Clin Cancer Res. 1997 Jun;3(6):947-54. Clin Cancer Res. 1997. PMID: 9815770

8

Identification and characterization of a deletion mutant of DNA topoisomerase I mRNA in a camptothecin-resistant subline of human colon carcinoma.

Yanase K, Sugimoto Y, Tsukahara S, Oh-Hara T, Andoh T, Tsuruo T. Yanase K, et al. Among authors: tsuruo t. Jpn J Cancer Res. 2000 May;91(5):551-9. doi: 10.1111/j.1349-7006.2000.tb00980.x. Jpn J Cancer Res. 2000. PMID: 10835501 Free PMC article.

9

Differential expression of DNA topoisomerase I gene between CPT-11 acquired- and native-resistant human pancreatic tumor cell lines: detected by RNA/PCR-based quantitation assay.

Takeda S, Shimazoe T, Sato K, Sugimoto Y, Tsuruo T, Kono A. Takeda S, et al. Among authors: tsuruo t. Biochem Biophys Res Commun. 1992 Apr 30;184(2):618-25. doi: 10.1016/0006-291x(92)90634-w. Biochem Biophys Res Commun. 1992. PMID: 1315526

10

C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance.

Imai Y, Nakane M, Kage K, Tsukahara S, Ishikawa E, Tsuruo T, Miki Y, Sugimoto Y. Imai Y, et al. Among authors: tsuruo t. Mol Cancer Ther. 2002 Jun;1(8):611-6. Mol Cancer Ther. 2002. PMID: 12479221

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

714 results

Search Page

Filters